CN103432522A - Chinese medicine formula for treating hyperlipidemia - Google Patents
Chinese medicine formula for treating hyperlipidemia Download PDFInfo
- Publication number
- CN103432522A CN103432522A CN2013103767881A CN201310376788A CN103432522A CN 103432522 A CN103432522 A CN 103432522A CN 2013103767881 A CN2013103767881 A CN 2013103767881A CN 201310376788 A CN201310376788 A CN 201310376788A CN 103432522 A CN103432522 A CN 103432522A
- Authority
- CN
- China
- Prior art keywords
- gram
- chinese medicine
- medicine formula
- semen
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicine formula for treating hyperlipidemia, and relates to the technical field of traditional Chinese medicines. The Chinese medicine formula comprises the components: rhizoma alismatis, rhizoma polygonati, polygonum multiflorum, semen trigonellae, semen cassia, eucommia ulmoides, hawthorn, radix curcumae longae, lotus leaf, root of red-rooted salvia, black soya bean and Chinese-date. The Chinese medicine formula can be used as a Chinese medicine prescription, can be decocted to take orally, and can also be prepared into pills to take orally. The Chinese medicine formula disclosed by the invention is scientific and reasonable in combination, available in materials, simple in preparation method, short in course of treatment, and good in treatment effect; the Chinese medicine formula compounded by a plurality of medicines has the functions of promoting blood circulation to remove blood stasis, tonifying the liver and kidney, promoting blood circulation to remove meridian obstruction, reducing cholesterol absorption, and reducing blood fat, so as to achieve an effect of treating the hyperlipidemia. The effect of the Chinese medicine formula is significant in clinical application; the effective rate is 95.48%.
Description
Technical field:
The present invention relates to the Chinese medicine technical field, be specifically related to a kind of Chinese medicine formula for the treatment of hyperlipidemia.
Technical background:
Hyperlipemia is a kind of common multiple disease, and two kinds of former and secondary are arranged.Former, the Inheritance history is arranged more; Secondary, be secondary to disease and the chronic alcoholism of the internal organs such as unsteered diabetes, hypothyroidism, liver, gallbladder, pancreas, kidney more.
The clinical manifestation of hyperlipemia is atherosclerosis, blood pressure is higher, fat, abdomen is sick, erythra, hepatosplenomegaly, blood test is that cholesterol, triglyceride, blood viscosity increase, simultaneously in blood the content of one or more lipoprotein compositions higher than the normal person.Serious atherosclerosis can cause coronary heart disease, apoplexy (cerebral hemorrhage, cerebral thrombosis, transient ischemic attack), renal damage, retinal hemorrhage and two lower limb blood supply insufficiency, and its result produces very high case fatality rate and disability rate.
In clinical treatment, western medicine, but, because the toxic and side effects of Western medicine is larger, can cause Liver and kidney directly to damage, and some patients were can not tolerate, and the control of part blood fat is bad, and overall therapeutic effect can not be satisfactory.
The traditional Chinese medical science is thought, kidney qi virtual loss, spleen renal dysfunction, dysfunction of the spleen in transportation and transformation, disturbance in functioning of QI, cause blood flow rate to slow down, defeatedization of cream fat is unfavorable in addition, and serum lipid concentrations raises, and filthy turbid lipidosis is in blood vessel, hindering blood flow normally moves, be form hyperlipemia pathologic basis, the key of Chinese traditional treatment hyperlipemia is that the expectorant stasis of blood is laid equal stress on, removing both phlegm and blood stasis at the same time, the pathogenesis that just can hit, reduce the blood fat effect.
Summary of the invention:
The present invention is in order to address the above problem, and a kind of Chinese medicine formula that is used for the treatment of hyperlipidemia is provided, and has blood circulation promoting and blood stasis dispelling, and liver and kidney tonifying, promoting blood circulation to remove obstruction in the collateral reduce cholesterol absorption, reduces blood fat and reaches treatment hyperlipemia effect.
Technical scheme of the present invention is: a kind of Chinese medicine formula that is used for the treatment of hyperlipidemia, by Rhizoma Alismatis, Rhizoma Polygonati, Radix Polygoni Multiflori, Semen Trigonellae, Semen Cassiae, the Cortex Eucommiae, Fructus Crataegi, Rhizoma Curcumae Longae, Folium Nelumbinis, Radix Salviae Miltiorrhizae, Semen sojae atricolor, Fructus Jujubae, formed, this Chinese medicine formula can be used as Chinese medicinal formulae, decocting is for oral administration, also can be made into pill for oral administration.
Above-mentioned Chinese medicinal formulae decocting is for oral administration, and its compatibility of medicines in a prescription dosage is: Rhizoma Alismatis 10-15 gram, Rhizoma Polygonati 10-15 gram, Radix Polygoni Multiflori 10-20 gram, Semen Trigonellae 10-15 gram, Semen Cassiae 10-12 gram, Cortex Eucommiae 10-15 gram, Fructus Crataegi 10-20 gram, Rhizoma Curcumae Longae 10-15 gram, Folium Nelumbinis 10-12 gram, Radix Salviae Miltiorrhizae 10-15 gram, Semen sojae atricolor 10-30 gram, Fructus Jujubae 25-50 gram.
It is for oral administration that above-mentioned Chinese medicinal formulae is made pill, and its compatibility of medicines in a prescription dosage is: Rhizoma Alismatis 20-30 gram, Rhizoma Polygonati 20-30 gram, Radix Polygoni Multiflori 20-30 gram, Semen Trigonellae 20-25 gram, Semen Cassiae 20-25 gram, Cortex Eucommiae 20-30 gram, Fructus Crataegi 30-40 gram, Rhizoma Curcumae Longae 25-35 gram, Folium Nelumbinis 20-25 gram, Radix Salviae Miltiorrhizae 20-30 gram, Semen sojae atricolor 20-30 gram, Fructus Jujubae 50-60 gram.Above-mentioned Chinese medicine is mixed and grinds to the powder altogether, after crossing 150 mesh sieves, make Chinese medicine pill, can take.
Side separates:
Rhizoma Alismatis: the wide spectrum blood fat reducing, fall blood sheet, antithrombotic and form; Radix Polygoni Multiflori, the Cortex Eucommiae: replenishing vital essence and blood, liver and kidney tonifying, reduce cholesterol and attract and internal deposition; Fructus Crataegi: blood fat reducing, regulate cardiovascular function; Folium Nelumbinis: there is blood fat reducing, blood pressure lowering, expelling summer-heat; Semen Cassiae: blood pressure lowering, strong diuresis are arranged, reduce cholesterol absorption; Semen Trigonellae, Rhizoma Polygonati, Semen sojae atricolor, Fructus Jujubae: promoting blood circulation to remove obstruction in the collateral, reduce serum total cholesterol, delay arteriosclerosis, prevent from causing the blood vessel wall infringement; Rhizoma Curcumae Longae, Radix Salviae Miltiorrhizae: blood circulation promoting and blood stasis dispelling, blood fat reducing, antithrombotic forms.
Usage and curative effect:
Decocting is for oral administration, and every day, potion, took orally at twice, and triglyceride, more than normal value, below 5.0mmol/L, one month is a course for the treatment of, and triglyceride, more than 5.0mmol/L, can need two courses for the treatment of.
Pill is for oral administration, every day three times, and each 4-6 gram, triglyceride, more than normal value, below 5.0mmol/L, two months is a course for the treatment of, triglyceride, more than 5.0mmol/L, can need two courses for the treatment of.
Beneficial effect of the present invention: this preparation is used for the treatment of hyperlipemia, has the T-CHOL of reduction, triglyceride, low density lipoprotein, LDL effect, and therapeutic effect is good, short treating period, and the characteristics that have no side effect, facilitate clinical practice.This Chinese medicine formula combination is scientific and reasonable, and raw material is easy to get, and preparation method is simple, short treating period, therapeutic effect is good, and the Chinese medicine formula that all medicines are synthetic, have blood circulation promoting and blood stasis dispelling, liver and kidney tonifying, promoting blood circulation to remove obstruction in the collateral, reduce cholesterol absorption, reduces blood fat and reach treatment hyperlipemia effect.Through clinical practice, effect is fairly obvious, effective percentage 95.48%.
The specific embodiment:
Describe Chinese medicine formula of the present invention in detail below in conjunction with specific embodiment:
1 one kinds of Chinese medicine formulas for the treatment of hyperlipidemia of embodiment.
Take Rhizoma Alismatis 12 grams, Rhizoma Polygonati 10 grams, Radix Polygoni Multiflori 12 grams, Semen Trigonellae 12 grams, Semen Cassiae 10 grams, the Cortex Eucommiae 12 grams, Fructus Crataegi 15 grams, Rhizoma Curcumae Longae 12 grams, Folium Nelumbinis 10 grams, Radix Salviae Miltiorrhizae 12 grams, Semen sojae atricolor 20 grams, Fructus Jujubae 30 grams.Above-mentioned Chinese medicine decocting is for oral administration, every day potion, decocting is for oral administration at twice.
2 one kinds of Chinese medicine formulas for the treatment of hyperlipidemia of embodiment.
Take Rhizoma Alismatis 24 grams, Rhizoma Polygonati 20 grams, Radix Polygoni Multiflori 24 grams, Semen Trigonellae 24 grams, Semen Cassiae 20 grams, the Cortex Eucommiae 24 grams, Fructus Crataegi 30 grams, Rhizoma Curcumae Longae 25 grams, Folium Nelumbinis 20 grams, Radix Salviae Miltiorrhizae 25 grams, Semen sojae atricolor 25 grams, Fructus Jujubae 50 grams.Above-mentioned Chinese medicine is mixed and grinds to the powder altogether, after crossing 150 mesh sieves, make Chinese medicine pill, every day three times, each 4-6 gram is for oral administration.
The above, be only the specific embodiment of the present invention, but protection scope of the present invention is not limited to this, and any variation of expecting without creative work or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (3)
1. a Chinese medicine formula for the treatment of hyperlipidemia, is characterized in that the component of formula is: Rhizoma Alismatis, Rhizoma Polygonati, Radix Polygoni Multiflori, Semen Trigonellae, Semen Cassiae, the Cortex Eucommiae, Fructus Crataegi, Rhizoma Curcumae Longae, Folium Nelumbinis, Radix Salviae Miltiorrhizae, Semen sojae atricolor, Fructus Jujubae.This Chinese medicine formula can be used as Chinese medicinal formulae, and decocting is for oral administration, also can be made into pill for oral administration.
2. the Chinese medicine formula for the treatment of hyperlipidemia according to claim 1, for oral administration as water decoction, its compatibility of medicines in a prescription dosage is: Rhizoma Alismatis 10-15 gram, Rhizoma Polygonati 10-15 gram, Radix Polygoni Multiflori 10-20 gram, Semen Trigonellae 10-15 gram, Semen Cassiae 10-12 gram, Cortex Eucommiae 10-15 gram, Fructus Crataegi 10-20 gram, Rhizoma Curcumae Longae 10-15 gram, Folium Nelumbinis 10-12 gram, Radix Salviae Miltiorrhizae 10-15 gram, Semen sojae atricolor 10-30 gram, Fructus Jujubae 25-50 gram.
3. the Chinese medicine formula for the treatment of hyperlipidemia according to claim 1, make pill for oral administration, its compatibility of medicines in a prescription dosage is: Rhizoma Alismatis 20-30 gram, Rhizoma Polygonati 20-30 gram, Radix Polygoni Multiflori 20-30 gram, Semen Trigonellae 20-25 gram, Semen Cassiae 20-25 gram, Cortex Eucommiae 20-30 gram, Fructus Crataegi 30-40 gram, Rhizoma Curcumae Longae 25-35 gram, Folium Nelumbinis 20-25 gram, Radix Salviae Miltiorrhizae 20-30 gram, Semen sojae atricolor 20-30 gram, Fructus Jujubae 50-60 gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013103767881A CN103432522A (en) | 2013-08-26 | 2013-08-26 | Chinese medicine formula for treating hyperlipidemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013103767881A CN103432522A (en) | 2013-08-26 | 2013-08-26 | Chinese medicine formula for treating hyperlipidemia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103432522A true CN103432522A (en) | 2013-12-11 |
Family
ID=49686306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013103767881A Pending CN103432522A (en) | 2013-08-26 | 2013-08-26 | Chinese medicine formula for treating hyperlipidemia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432522A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104042803A (en) * | 2014-07-15 | 2014-09-17 | 董宝珍 | Traditional Chinese medicinal liquor for treating hyperlipemia and brewing method thereof |
CN105999054A (en) * | 2016-05-24 | 2016-10-12 | 辽宁佰福药业有限公司 | Rose diet tea prepared from medical juice and preparation method of rose diet tea |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686352A (en) * | 2005-04-14 | 2005-10-26 | 广西灵峰药业有限公司 | Medicine for treating high lipemia and its production method |
CN1895623A (en) * | 2006-06-19 | 2007-01-17 | 天津中医药大学 | Medicinal composition for treating fatty liver, its preparation and use |
CN101406644A (en) * | 2007-10-11 | 2009-04-15 | 秦淑萍 | Medicament with function for reducing blood sugar |
CN102000299A (en) * | 2010-11-09 | 2011-04-06 | 赵晓红 | Medicine for treating hyperlipidaemia |
CN102886024A (en) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | Composition with function of aiding to reduce blood fat and preparation method of composition |
-
2013
- 2013-08-26 CN CN2013103767881A patent/CN103432522A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686352A (en) * | 2005-04-14 | 2005-10-26 | 广西灵峰药业有限公司 | Medicine for treating high lipemia and its production method |
CN1895623A (en) * | 2006-06-19 | 2007-01-17 | 天津中医药大学 | Medicinal composition for treating fatty liver, its preparation and use |
CN101406644A (en) * | 2007-10-11 | 2009-04-15 | 秦淑萍 | Medicament with function for reducing blood sugar |
CN102000299A (en) * | 2010-11-09 | 2011-04-06 | 赵晓红 | Medicine for treating hyperlipidaemia |
CN102886024A (en) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | Composition with function of aiding to reduce blood fat and preparation method of composition |
Non-Patent Citations (2)
Title |
---|
无: ""脂肪肝"", 《湖南中医药导报》 * |
苏孝共等: ""降脂中药的性效辨析及机理探讨"", 《中医药学刊》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104042803A (en) * | 2014-07-15 | 2014-09-17 | 董宝珍 | Traditional Chinese medicinal liquor for treating hyperlipemia and brewing method thereof |
CN105999054A (en) * | 2016-05-24 | 2016-10-12 | 辽宁佰福药业有限公司 | Rose diet tea prepared from medical juice and preparation method of rose diet tea |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101274084A (en) | Medicament for curing hypertension, hyperlipemia and complication thereof | |
CN103751566A (en) | Traditional Chinese medicinal prescription for treating hypertension | |
CN102526691A (en) | External application plaster for treating dysmenorrhea | |
CN104027500A (en) | Traditional Chinese medicinal formula for treating high blood fat, hypercholesterolemia and high blood viscosity | |
CN103211885B (en) | Chinese medicinal composition for treatment of chronic urticaria | |
CN103055116A (en) | Traditional Chinese medicine composition for treating acnes | |
CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
CN102198228A (en) | Chinese medicinal preparation for treating hypertension | |
CN103432522A (en) | Chinese medicine formula for treating hyperlipidemia | |
CN103479768A (en) | Composite traditional Chinese medicine compound for treating chronic lymphocytic thyroiditis | |
CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
CN102274482A (en) | Chinese medicinal preparation for treating diabetes | |
CN104587370B (en) | A kind of Chinese medicine composition for treating hepatic sclerosis | |
CN104667052A (en) | Traditional Chinese medicinal formula for treating superficial gastritis | |
CN105963635A (en) | Traditional Chinese medicinal composition for treating headache | |
CN103432467B (en) | Traditional Chinese medicine used for treating uremia and preparation method thereof | |
CN102389479A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN106344692A (en) | Chinese medicine prescription for losing weight | |
CN102038827A (en) | Chinese medicinal preparation for treating diabetes with hypertension | |
CN105287949A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN102100842A (en) | Traditional Chinese medicine preparation used for treating diaphragmatic spasm | |
CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
CN1559471A (en) | Chinese medicine/preparation | |
CN1293049A (en) | 'Shexingkeyu' capsule for treating cardiovascular and cerebrovascular diseases and its preparing process | |
CN103041335A (en) | Traditional Chinese medicine composition for treating gastralgia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131211 |